Specialty Pharmacy

Writer and neurologist Oliver Sacks confirms he has terminal cancer of the liver.

Avella Specialty Pharmacy has been selected by Bayer HealthCare as one of the limited group of specialty pharmacies authorized to distribute 2 of the manufacturer's oral oncology drugs.

Celgene today announced that the FDA has granted an expanded use approval for its multiple myeloma drug, lenalidomide (Revlimid).

Experimental device offers non-invasive method to diagnose disease.

Multiple strains of HIV recombine into new variant.

Baxter International recently revealed new data from a phase 3 pivotal study of its investigational drug, BAX 855, an extended half-life recombinant factor VIII treatment for hemophilia A.

As genomic medicine continues to advance, school curricula will have to evolve so that the health care team can become more genetically literate.

Activation of protein causes cells to change shape and become motile.

Thomas Morrow, MD, chief medical officer at Next IT, discusses effective integration of virtual health assistants into existing services of specialty pharmacy.

Genetic variants found that are associated with psoriatic arthritis, but not psoriasis.

Enzyme associated with metabolic programming may lead to new treatments.

Company again selected as limited distribution pharmacy provider.

The FDA is seeking comments on 28 new and 15 revised recommendations providing product-specific guidance on the design of bioequivalence studies to support Abbreviated New Drug Applications (ANDAs).

Researchers examine the potential of creating new eggs with stem cells.

Narcotics are not recommended for managing chronic pain in children with inflammatory bowel disease, due to gastrointestinal side effects and potential dependence. Nevertheless, researchers have uncovered that long-term narcotic use is more than twice as prevalent in pediatric IBD patients compared with the general population.

Study examines how side effects from commonly used antibiotics effect mitochondria of cancer cells.

Mosquito-borne virus causes joint pain and swelling similar to rheumatoid arthritis.

The FDA today approved Eisai's kinase inhibitor, lenvatinib (Lenvima), for the treatment of differentiated thyroid cancer in patients whose disease progressed despite receiving radioactive iodine therapy.

Diabetics who took metformin saw a decreased chance of developing adenocarcinoma.

Following widespread concerns about counterfeit pharmaceuticals in the early 2000s, the FDA and individual states began reconsidering the design of the pharmaceutical supply chain.

A new Affordable Care Act initiative from HHS will better coordinate cancer care with the intention of improving the quality of care provided and reducing the money spent on healthcare.

Scientists map pathological progress of disease.

Spontaneous cure achieved in first person documented with WHIM Syndrome.

Annual rate of primary tumor removal has decreased since 1988.

Cells found to hijack vitamin D receptors to repair damage caused by therapy.

Raulo Frear, PharmD, general manager of OmedaRx, discusses the ramifications of biosimilars hitting the US market.

Trend reflects growing tobacco epidemic among women.

Biological process may lead to failure of embryo to attach to uterine wall.

Avella Specialty Pharmacy announced today that it has been selected by Pfizer as one of the limited groups of specialty pharmacies authorized to distribute the manufacturer's breakthrough breast cancer drug-Ibrance (palbociclib)-which has just received fast-tracked approval from the FDA.

Antiretroviral therapy has led to remarkable improvements in HIV-infected individuals. By suppressing HIV RNA to